Rahul Ravind

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

Vijay Patil, Vanita Noronha, Sachin Dhumal et al. · The Lancet Global Health · 2020 · 98 citations · Full text

Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation

Vijay Patil, Vanita Noronha, Nandini Menon et al. · Journal of Clinical Oncology · 2023 · 77 citations

Radiation dose to dysphagia aspiration-related structures and its effect on swallowing: Comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy plans

ChelakkotG Prameela, Rahul Ravind, P.S. Renil Mon et al. · Journal of Cancer Research and Therapeutics · 2016 · 18 citations · Full text

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort

Jyoti Bajpai, Lakhan Kashyap, Dilip Harindran Vallathol et al. · The Breast · 2022 · 12 citations · Full text